# A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

Study · id `cardio:ct-nct06949020` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06949020](<https://clinicaltrials.gov/study/NCT06949020>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06949020

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

## Technical summary

Registry record NCT06949020. Randomized; triple masking; primary purpose treatment. Start 2025-07-09 (actual); primary completion 2026-03-14 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 160 participants (enrolled count; ClinicalTrials.gov record NCT06949020, source copy `cardio:ctgov-nct06949020-2026-08-06`, retrieved 2026-10-26)
- Started: 2025-07-09 (actual) (ClinicalTrials.gov record NCT06949020, source copy `cardio:ctgov-nct06949020-2026-08-06`, retrieved 2026-10-26)
- Primary completion: 2026-03-14 (actual) (ClinicalTrials.gov record NCT06949020, source copy `cardio:ctgov-nct06949020-2026-08-06`, retrieved 2026-10-26)
- Completion: 2026-04-26 (actual) (ClinicalTrials.gov record NCT06949020, source copy `cardio:ctgov-nct06949020-2026-08-06`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06949020, source copy `cardio:ctgov-nct06949020-2026-08-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06949020-2026-08-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema
- Condition: Cardiac Edema
- Intervention (Drug): JMKX003142 Injection
- Intervention (Drug): JMKX003142 Injection
- Intervention (Drug): JMKX003142 Injection
- Intervention (Drug): JMKX003142 placebo
- Lead sponsor: Jemincare
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: fd940de9216e43918fa760eb65a07ec7ed1bc060ee902c151b7fb23cdb5f12d6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
